Ligand Pharmaceuticals Incorporated (NASDAQ:LGND)
Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) represented a move of 5.04 percent or $4.8 per share and closed its previous day trading session at $171.19. 1.57 Million Shares were traded in the last trading session with an Average Volume of 598.46 Million Shares. The stock currently has a Market Capitalization of 3.73 Billion.
Ligand Pharmaceuticals Incorporated discovers, develops and markets new drugs that address critical unmet medical needs of patients in the areas of cancer, pain, skin diseases, men’s and women’s hormone-related diseases, osteoporosis, metabolic disorders, and cardiovascular and inflammatory diseases. Ligand’s proprietary drug discovery and development programs are based on its leadership position in gene transcription technology, primarily related to intracellular receptors.
The stock traded between $126.50 and $278.62 over 1-Year time period showing its price to sales ratio of 16.23. Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) is currently showing an DECREASING volatility over a period of 10-Days while the 20-Days Volatility showing a DECREASING trend.
Right now, the stock has a 50-Day Simple Moving Average of $-24.51 and 200-Day Simple Moving Average of $-13.47. Its Price to Free Cash Flow is 19.55 and Price to Book of 5.86.
Analyst’s recommended the stock as 1.9 where 1 represents Strong Buy and 5 represents Sell.
In the last Quarter, Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) reported its Actual EPS of $1.32/share. The analysts offering Earnings Estimates for the company were believing that Ligand Pharmaceuticals Incorporated could bring EPS of $1.03/share. The difference between Actual EPS and Estimated EPS was 0.29 Percent. Thus showing an Earnings Surprise of 28.2 Percent.
Jabil Inc. (NYSE:JBL)
In the last trading session, Jabil Inc. (NYSE:JBL) added its value by -0.69% closing at the price of $25.85. The stock currently has market capitalization of 4.13 Billion, with average volume of 1.78 Million shares.
Beta is also a factor of measure of the relative volatility of a particular stock to the market. Currently Jabil Inc. (NYSE:JBL) is showing beta of 0.53. This particular value of beta suggests that Jabil Inc. (NYSE:JBL) has historically moved 53% for every 100% move in the benchmark, based on price level.
EPS is another important factor while making the decision of buying, selling or holding of particular share. Currently EPS for Jabil Inc. (NYSE:JBL) is at $1.31.
The stock currently has RSI of 53.8. RSI is considered overbought when above 70 and oversold when below 30, currently the given RSI for the stock suggests that the stock is average and it has not entered in overbought or oversold territory.
Jabil Inc. provides electronic manufacturing services and solutions. The Company’s operating segment includes Electronics Manufacturing Services and Diversified Manufacturing Services. EMS segment is focused on leveraging information technology, supply chain design and engineering, technologies centered on core electronics. DMS segment is focused on providing engineering solutions and a focus on material sciences and technologies. It provides electronic design, production and product management services to automotive, capital equipment, consumer lifestyles and wearable technologies, computing and storage, defense and aerospace, digital home, emerging growth, healthcare, industrial and energy, mobility, packaging, point of sale and printing industries. Jabil Inc., formerly known as Jabil Circuit Inc., is based in FL, United States.
Jabil Inc. (NYSE:JBL) topped its 52-week high price of $31.77 on 03/19/18 and 52-Week Low Price of $23.04 on 10/26/18. The Stock currently has P/E (price to earnings ttm) of 19.75 and Weekly volatility of 2.05% and monthly volatility of 2.76% respectively.